Answer
Reported blood cell abnormalities with capreomycin sulfate include leucocytosis, leucopenia, rare thrombocytopenia, and eosinophilia exceeding 5% in most patients receiving daily treatment, which subsided when dosing was reduced to two or three times weekly.
Sources for this answer
- Capreomycin InjectionNeon Healthcare Ltd · emc · SmPC §4.8 Undesirable effects · Version 1Document updated
Sources checked